A: Tirzepatide is recommended for adults with a BMI of 30 or higher, or a BMI of 27 or higher with weight-related health conditions
Our team ensures that each patient receives personalized care and guidance for the best possible results
Safety Considerations for Lower BMI Patients Using GLP-1s The primary safety concern for lower BMI individuals taking GLP-1 medications is unintended muscle loss and nutritional deficiency, particularly if caloric intake drops too far below maintenance needs
Accordingly, claims of long-term structural renoprotection should be interpreted cautiously until kidney-focused trials and longer follow-up data confirm benefits on hard renal endpoints (eGFR slope, ESKD)
[2] Helpful Note: Switch to whole, nutrient-dense foods like leafy greens, fruits, nuts and other antioxidant-rich options
A dietary trial of foods that are lower in mold could be tried